article thumbnail

IISc researchers find picolinic acid’s broad-spectrum antiviral abilities, scouts for partners in pharma companies

AuroBlog - Aurous Healthcare Clinical Trials blog

The Institute is now looking for partners in pharma companies to pursue further clinical development of the findings. Researchers at the Indian Institute of Science (IISc) have found that picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses.

article thumbnail

Indian healthcare providers and pharma companies speed up to combat TB as drug resistance concerns emerge

AuroBlog - Aurous Healthcare Clinical Trials blog

Indian healthcare providers and pharma companies pace up their efforts with early detection and research for new medicines to combat the spread of tuberculosis as drug resistance concerns emerge. TB is a significant public health threat, with an estimated 10 million annual cases. India shares the highest TB burden with 2.69

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma companies team-up to reduce emissions  

Drug Discovery World

The Task Force will now take collective action to address emissions across three priority areas: supply chains, patient care pathways and clinical trials. The companies will agree on a set of common supplier standards designed to decarbonise the supply chain and will pursue green transportation corridors. Three areas of priority .

article thumbnail

Pfizer, marking fast research pace, starts key trial of RSV vaccine

Bio Pharma Dive

The pharma company is in a tight race with rivals, including GSK, to become the first with an approved shot for the infectious disease.

article thumbnail

Report urges pharma companies to utilise synthetic data in clinical trials

Pharma Times

Report outlines two cases for using synthetic data in the clinical trial process

article thumbnail

How Pharma Companies Can – And Should – Improve Social Determinants of Health

Intouch Solutions

Pharmaceutical companies can sponsor as well as provide these leaders. Pharmaceutical companies can increase diversity in their clinical trials. Companies can also support pre-existing SDOH research initiatives. Studies should include as detailed SDOH data as possible.

article thumbnail

Boehringer Ingelheim Aims to Bring 25 New Products to Market by 2030

BioSpace

The German bio pharma company on Tuesday announced ambitious pipeline plans that include starting 10 new Phase II and III trials over the next 12 to 18 months.